Chief Scientific Officer, Chairman
preclinical and clinical development
Javier Rivela, MBA, CFA Chief Executive Officer Co-Founder Mr. Rivela has over 12 years experience in investment banking. Prior work includes co-head of ING’s European Small & Mid Cap Research Team where he was engaged in over 10 European biotech IPO/secondary placement transactions. He has held equity research positions at Banco Santander in Madrid and Redwood Securities in San Francisco, and in credit risk analysis at Chevron-Texaco in Concord, CA.